We examined the expression of cytokeratin 20 (CK20) mRNA in the peripheral blood of oral squamous cell carcinoma (SCC) patients by reverse transcriptase polymerase chain reaction (RT-PCR). Eleven out of 12 oral SCC patients showed positive RT-PCR results. However, there is no clear relationship between the haematogenous CK20 mRNA and the metastasis. After initial treatment, all of the tumour-free survivors tested showed negative RT-PCR results. CK20 mRNA in peripheral blood can be used as a marker for tumour recurrence but not for metastasis in oral SCC patients.
CITATION STYLE
Kawamata, H., Uchida, D., Nakashiro, K., Hino, S., Omotehara, F., Yoshida, H., & Sato, M. (1999). Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. British Journal of Cancer, 80(3–4), 448–452. https://doi.org/10.1038/sj.bjc.6690377
Mendeley helps you to discover research relevant for your work.